FDA MedWatch - Specific Lots of Aerosol Sunscreen Spray Products by Coppertone:

If your email program has trouble displaying this email, view as a webpage.

TOPIC: Specific Lots of Aerosol Sunscreen Spray Products by Coppertone: Recall - Due to the Presence of Benzene

AUDIENCE: Consumer, Health Professional, Pharmacy, Dermatology

ISSUE:  Coppertone is recalling twelve lots of five Coppertone aerosol sunscreen spray products manufactured between the dates of January 10, 2021 and June 15, 2021.

Coppertone has identified the presence of benzene in these lots. Benzene is classified as a human carcinogen. Exposure to benzene can occur through inhalation, oral, and skin and it could, depending on the level and extent of exposure, result in an increased risk of cancers including leukemia, and blood cancer of the bone marrow and other blood disorders which can be life-threatening.

The specific products recalled are:

• Coppertone Pure & Simple SPF 50 5.0 oz aerosol sunscreen spray
  • (Lot# TN00CJ4, Lot# TN00BR2)
• Coppertone Pure & Simple Kids SPF 50 5.0 oz aerosol sunscreen spray
  • (Lot# TN00857, Lot# TN00CJV, Lot# TN00854, Lot# TN00855)
• Coppertone Pure & Simple Baby SPF 50 5.0 oz aerosol sunscreen spray
  • (Lot# TN009GH, Lot# TN0083K, Lot# TN0083J)
• Coppertone Sport Mineral SPF 50 5.0 oz aerosol sunscreen spray
  • (Lot# TN008KU, Lot# TN008KV)
• Travel-size Coppertone Sport Spray SPF 50 1.6 oz aerosol sunscreen spray
  • (Lot# TN00BU3)

To date, Coppertone has not received any reports of adverse events related to this recall.

For more information about this recall, click on the red button "Read Recall" below.

RECOMMENDATIONS: 

• Consumers should stop using these specific Coppertone aerosol sunscreen spray products and dispose of them appropriately.
• Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these aerosol sunscreen spray products.

Health professionals and consumers are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.